Literature DB >> 2784547

Spinal cord stimulation for relief of chronic pain in vasospastic disorders of the upper limbs.

F J Robaina1, M Dominguez, M Díaz, J L Rodriguez, J A de Vera.   

Abstract

Eleven patients with chronic pain due to severe vasospastic disorders in the upper limbs were treated with cervical spinal cord stimulation. In 8 patients the pain was due to reflex sympathetic dystrophy in the late stage of the disease, and 3 patients had severe idiopathic Raynaud's disease. The mean follow-up for both groups was 27 months. A total of 10 patients (90.9%) had good or excellent results. Thermographic and plethysmographic changes were observed in both groups. There seems to be a very close relationship between the increase of blood flow and the amount of pain relief achieved. In an attempt to quantify the intensity of pain, the visual analog scale and McGill Pain Questionnaire were used. Stimulation proved to be harmless, with no mortality and very low morbidity. The latter centered around local infection and displacement of the electrodes. No objective changes occurred in trophic alterations such as bone decalcification and ankylosis, but there were improvements in the alterations in the nails and skin. In the reflex sympathetic dystrophy group, the amount of pain relief achieved enabled most patients to undergo subsequent physiotherapy and rehabilitation. In severe cases of reflex sympathetic dystrophy and idiopathic Raynaud's disease, spinal cord stimulation is an alternative treatment that can be used as primary therapy or as secondary therapy after unsuccessful sympathectomy or sympathetic blocks.

Entities:  

Mesh:

Year:  1989        PMID: 2784547     DOI: 10.1227/00006123-198901000-00010

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  9 in total

Review 1.  Neuromodulation: spinal cord and peripheral nerve stimulation.

Authors:  M Day
Journal:  Curr Rev Pain       Date:  2000

2.  Modification of loco-regional microenvironment in brain tumors by spinal cord stimulation. Implications for radio-chemotherapy.

Authors:  B Clavo; F Robaina; B Valcarcel; L Catala; J L Perez; A Cabezon; I J Jorge; D Fiuza; M A Hernandez; R Jover; J L Carreras
Journal:  J Neurooncol       Date:  2011-07-12       Impact factor: 4.130

3.  Treatment of complex regional pain syndrome type I of the hand with a series of intravenous regional sympathetic blocks with guanethidine and lidocaine.

Authors:  Kosmas I Paraskevas; Alexandra A Michaloglou; Despina D Briana; Maria Samara
Journal:  Clin Rheumatol       Date:  2005-12-07       Impact factor: 2.980

4.  Evidence based guidelines for complex regional pain syndrome type 1.

Authors:  Roberto S Perez; Paul E Zollinger; Pieter U Dijkstra; Ilona L Thomassen-Hilgersom; Wouter W Zuurmond; Kitty Cj Rosenbrand; Jan H Geertzen
Journal:  BMC Neurol       Date:  2010-03-31       Impact factor: 2.474

5.  Spinal cord stimulation and cerebral haemodynamics.

Authors:  M Meglio; B Cioni; M Visocchi; F Nobili; G Rodriguez; G Rosadini; F Chiappini; S Sandric
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

6.  Changes in mechanical responsiveness of the rat aorta after cervical spinal cord stimulation.

Authors:  J L Gil-Salú; J M Gonzalez-Darder
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

Review 7.  Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies.

Authors:  Mingyuan Wu; Bengt Linderoth; Robert D Foreman
Journal:  Auton Neurosci       Date:  2008-02-29       Impact factor: 3.145

Review 8.  Current and future trends in spinal cord stimulation for chronic pain.

Authors:  T R Deer
Journal:  Curr Pain Headache Rep       Date:  2001-12

9.  Assessment of spinal cord stimulation and radiofrequency: Chronic pain and psychological impact.

Authors:  Francesco Corallo; Simona De Salvo; Daniela Floridia; Lilla Bonanno; Nunzio Muscarà; Francesco Cerra; Cecilia Cannistraci; Marcella Di Cara; Viviana Lo Buono; Placido Bramanti; Silvia Marino
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.